Number of Shares
195,700.00
Current Holdings Value*
$1.19 Mil
% of Portfolio
7.6%
Total Estimate Gain
$-69,058.50
% of Total Estimate Gain
-3.88%

Lion Point Capital, LP's Fennec Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 195,700.00 shares of Fennec Pharmaceuticals Inc(FENC), totaling $1.19 Mil. This investment constitutes 7.6% of their stock portfolio, and Lion Point Capital, LP now holds 0.71% of the outstanding Fennec Pharmaceuticals Inc(FENC) stock.

The initial trade took place in 2023Q2. And since then Lion Point Capital, LP has made 3 purchases of FENC, at an average price of $8.27, for a total of 215,000.00 shares. In addition, there have been 1 sales at an average price of $5.13 for 19,300.00 shares. Based on historical transaction data and FENC's current price of $8.23, Lion Point Capital, LP's estimated gain on his FENC holdings is $-69,058.50, reflecting a -3.88% gain to date.

Lion Point Capital, LP FENC ($8.23) Holding Chart

Lion Point Capital, LP FENC ($8.23) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1